Paul D Gesellchen

age ~77

from Indianapolis, IN

Also known as:
  • Gesellchen D Paul
  • Paul N
Phone and address:
8039 Heyward Dr, Indianapolis, IN 46250
3175783816

Paul Gesellchen Phones & Addresses

  • 8039 Heyward Dr, Indianapolis, IN 46250 • 3175783816
  • 3816 Haverhill Ct, Indianapolis, IN 46240 • 3175783816

Resumes

Paul Gesellchen Photo 1

Principal

view source
Location:
8039 Heyward Dr, Indianapolis, IN 46250
Industry:
Pharmaceuticals
Work:
Pdg Regulatory Strategy Sep 2006 - Jul 31, 2017
Principal

Targanta Therapeutics 2006 - 2008
Vice President, Regulatory Affairs
Education:
University of Wisconsin - Madison 1970 - 1976
Doctorates, Doctor of Philosophy, Chemistry
University of Nebraska - Lincoln 1966 - 1970
Bachelors, Bachelor of Science, Chemistry
Westside High School
University of Nebraska–Lincoln
Skills:
Regulatory Affairs
Fda
Ind
Pharmaceutics
Chemistry
Regulatory Submissions
Nda
Strategy
Drug Development
Oncology
Regulatory Strategy
Drug Discovery
Pharmaceutical Industry
Clinical Trials
Peptide Synthesis
Clinical Development
Laboratory
Biopharmaceuticals
Pharmacology
Paul Gesellchen Photo 2

Principal - Pdg Regulatory Strategy Llc

view source
Position:
Principal at pdg Regulatory Strategy LLC
Location:
Indianapolis, Indiana Area
Industry:
Pharmaceuticals
Work:
pdg Regulatory Strategy LLC - Indianapolis, Indiana Area since Sep 2006
Principal

Targanta Therapeutics Sep 2006 - Jun 2008
Vice President, Regulatory Affairs

Targanta Therapeutics 2006 - 2008
VP Regulatory Affairs

Eli Lilly Jan 2004 - Sep 2006
Senior Scientific Director - Regulatory Affairs

Eli Lilly Jul 1990 - Jan 2004
Regulatory Affairs - Various
Education:
University of Wisconsin-Madison 1970 - 1976
PhD, Pharmaceutical Chemistry
University of Nebraska-Lincoln 1966 - 1970
BS, Chemistry

Us Patents

  • Pharmacologically Active Peptides

    view source
  • US Patent:
    43093434, Jan 5, 1982
  • Filed:
    Nov 25, 1980
  • Appl. No.:
    6/210210
  • Inventors:
    Paul D. Gesellchen - Indianapolis IN
  • Assignee:
    Eli Lilly and Company - Indianapolis IN
  • International Classification:
    C07C10352
  • US Classification:
    2601125E
  • Abstract:
    Compounds of the formula [R-Tyr-A-Gly-(N-R. sub. 1)Phe(p-Y)-X]. sub. 2 -(CH. sub. 2). sub. n in which R is hydrogen or methyl; A is the residue of a D-amino acid selected from the group consisting of Ala, Abu, Ser, Thr, and Met; R. sub. 1 is hydrogen, C. sub. 1 -C. sub. 3 primary alkyl, cyclopropylmethyl, or allyl; Y is hydrogen or fluoro; n is an integer from 1 to 10; and X is --NH-- or a group of the formula ##STR1## in which R. sub. 2 is hydrogen or C. sub. 1 -C. sub. 3 primary alkyl; R. sub. 3 is phenyl, 2-methylthioethyl, or isobutyl; or R. sub. 2 and R. sub. 3 taken together are --CH. sub. 2 --CH. sub. 2 --CH. sub. 2 --; subject to the limitation that, when R. sub. 2 is other than hydrogen, R. sub. 1 is hydrogen; are useful analgesic agents.
  • Pharmacologically Active Peptides

    view source
  • US Patent:
    42514398, Feb 17, 1981
  • Filed:
    Dec 17, 1979
  • Appl. No.:
    6/104345
  • Inventors:
    Paul D. Gesellchen - Indianapolis IN
    David L. Smiley - Greenfield IN
  • Assignee:
    Eli Lilly and Company - Indianapolis IN
  • International Classification:
    C07C10352
  • US Classification:
    2601125R
  • Abstract:
    Compound of the formula ##STR1## and pharmaceutically acceptable non-toxic acid addition salts thereof, in which L and D define the chirality; R. sub. 1 is hydrogen or C. sub. 1 --C. sub. 3 primary alkyl; R. sub. 2 is C. sub. 1 --C. sub. 4 primary or secondary alkyl, allyl, cyclopropylmethyl, C. sub. 1 --C. sub. 2 hydroxyalkyl, or --(CH. sub. 2). sub. m --U--CH. sub. 3 in which U is --S-- or >S--O and m is 1 or 2; R. sub. 3 is hydrogen, C. sub. 1 --C. sub. 4 primary or secondary alkyl, cyclopropylmethyl, or allyl; X is hydrogen, halo, hydroxy, C. sub. 1 --C. sub. 3 alkoxy, nitro, C. sub. 1 --C. sub. 3 alkyl, or trifluoromethyl; and Z is --CH. sub. 2 OR. sub. 4, ##STR2## in which R. sub. 4 is hydrogen or C. sub. 1 --C. sub.
  • Tripeptide Antithrombotic Agents

    view source
  • US Patent:
    54300231, Jul 4, 1995
  • Filed:
    Sep 14, 1993
  • Appl. No.:
    8/121134
  • Inventors:
    Paul D. Gesellchen - Indianapolis IN
    Robert T. Shuman - Greenwood IN
  • Assignee:
    Eli Lilly and Company - Indianapolis IN
  • International Classification:
    A61K 3800
    C07K 508
  • US Classification:
    514 18
  • Abstract:
    Thrombin inhibitors represented by the formula ##STR1## as provided wherein A(C. dbd. O)-- is, inter alia, phenylglycyl, cyclohexylglycyl, cyclohexenylglycyl, thienylglycyl or naphthylglycyl, wherein the. alpha. -amino group is preferably substituted by alkyl e. g. methyl or an alkoxycarbonyl, cycloalkoxycarbonyl or arylkoxycarbonyl group e. g. t-butyloxycarbonyl. A(C. dbd. O)-- also represents an. alpha. -substituted acetyl group such as. alpha. -methoxyphenylacetyl; or a bicyclic group such as a tetrahydroisoquinolin-1- or 3-carbonyl group; a perhydroisoquinolin -1- or -3-carbonyl group; or a 1-amino or (substituted amino) cycloalkylcarbonyl group such as 1-aminocyclohexylcarbonyl. Also provided are a method for inhibiting the formation of blood clots in man and animals by administering a thrombin inhibitor of the above formula and pharmaceutical formulations useful in the method.
  • Pharmacologically Active Peptides

    view source
  • US Patent:
    42833299, Aug 11, 1981
  • Filed:
    Dec 17, 1979
  • Appl. No.:
    6/104348
  • Inventors:
    Paul D. Gesellchen - Indianapolis IN
    Robert T. Shuman - Greenwood IN
  • Assignee:
    Eli Lilly and Company - Indianapolis IN
  • International Classification:
    C07C10352
    A61K 3700
  • US Classification:
    2601125R
  • Abstract:
    Compounds of the formula ##STR1## and pharmaceutically acceptable non-toxic acid addition salts thereof, in which L and D define the chirality; R. sub. 1 is hydrogen or C. sub. 1 -C. sub. 3 primary alkyl; R. sub. 2 is C. sub. 1 -C. sub. 4 primary or secondary alkyl, allyl, cyclopropylmethyl, C. sub. 1 -C. sub. 2 hydroxyalkyl, or --(CH. sub. 2). sub. m --U--CH. sub. 3 in which U is --S-- or >S--O and m is 1 or 2; R. sub. 3 is hydrogen, C. sub. 1 -C. sub. 4 primary or secondary alkyl, cyclopropylmethyl, or allyl; R. sub. 4 is hydrogen, C. sub. 1 -C. sub. 5 primary or secondary alkyl, --(CH. sub. 2). sub. n --X--(CH. sub. 2). sub. p --CH. sub. 3 in which X is --O--, --S--, >S--O or ##STR2## n is 1 or 2, and p is 0 or 1, phenyl, or monosubstituted phenyl in which the substituent is halo, hydroxy, C. sub. 1 -C. sub. 3 alkoxy, nitro, C. sub. 1 -C. sub. 3 alkyl, or trifluoromethyl; R. sub.
  • Pharmacologically Active Peptides

    view source
  • US Patent:
    43223397, Mar 30, 1982
  • Filed:
    Oct 20, 1980
  • Appl. No.:
    6/198896
  • Inventors:
    Paul D. Gesellchen - Indianapolis IN
    Robert T. Shuman - Greenwood IN
  • Assignee:
    Eli Lilly and Company - Indianapolis IN
  • International Classification:
    C07C10352
  • US Classification:
    2601125E
  • Abstract:
    Compounds of the formula ##STR1## and pharmaceutically acceptable non-toxic acid addition salts thereof, in which R is hydrogen, methyl, or ethyl; A is the residue of a D-amino acid selected from the group consisting of Ala, Abu, Nva, Val, Nle, Leu, Ile, Gly(Al), Gly(Cp), Met, Cys(Me), Met(O), Cys(Me) (O), Ser, Thr, and Hse; R. sub. 1 is hydrogen, C. sub. 1 -C. sub. 3 primary alkyl, cyclopropylmethyl, allyl, or propargyl; X is bromo, iodo, chloro, C. sub. 1 -C. sub. 3 alkyl, trifluoromethyl, or C. sub. 1 -C. sub. 2 alkoxy; B is the residue of a D- or L-amino acid lacking its carboxyl moiety and selected from the group consisting of Gly, Ala, Abu, Nva, Val, Nle, Leu, Ile, Pgl, Cys(Me), Cys(Me) (O), Cys(Me) (O. sub. 2), Cys(Et), Cys(Et) (O), Cys(Et) (O. sub. 2), Met, Met(O), Met(O. sub.
  • Pharmacologically Active Peptides

    view source
  • US Patent:
    42658080, May 5, 1981
  • Filed:
    Dec 17, 1979
  • Appl. No.:
    6/104529
  • Inventors:
    Paul D. Gesellchen - Indianapolis IN
    Robert T. Shuman - Greenwood IN
  • Assignee:
    Eli Lilly and Company - Indianapolis IN
  • International Classification:
    C07C10352
  • US Classification:
    2601125R
  • Abstract:
    Compounds of the formula ##STR1## and pharmaceutically acceptable non-toxic acid addition salts thereof, in which L and D define the chirality; R. sub. 1 is hydrogen or C. sub. 1 -C. sub. 3 primary alkyl; R. sub. 2 is C. sub. 1 -C. sub. 4 primary or secondary alkyl, allyl, cyclopropylmethyl, C. sub. 1 -C. sub. 2 hydroxyalkyl, or --(CH. sub. 2). sub. m --U--CH. sub. 3 in which U is --S-- or >S--O and m is 1 or 2; R. sub. 3 is hydrogen, C. sub. 1 -C. sub. 4 primary or secondary alkyl, cyclopropylmethyl, allyl or propargyl; and Z is --CH. sub. 2 OR. sub. 4, ##STR2## in which R. sub. 4 is hydrogen, acetyl, or acetoxymethyl and R. sub. 5 is C. sub. 1 -C. sub. 3 alkyl; are useful analgesic agents.
  • Pharmacologically Active Peptides

    view source
  • US Patent:
    43223400, Mar 30, 1982
  • Filed:
    Oct 20, 1980
  • Appl. No.:
    6/198900
  • Inventors:
    Robert T. Shuman - Greenwood IN
    Paul D. Gesellchen - Indianapolis IN
  • Assignee:
    Eli Lilly and Company - Indianapolis IN
  • International Classification:
    C07C10352
  • US Classification:
    2601125E
  • Abstract:
    Compounds of the formula ##STR1## and pharmaceutically acceptable non-toxic acid addition salts thereof, in which R is hydrogen, methyl, ethyl, cyclopropylmethyl, or allyl; A is a residue of a D-amino acid selected from the group consisting of Ala, Abu, Nva, Val, Nle, Leu, Ile, Gly(Al), Gly(Cp), Met, Cys(Me), Met(O), Cys(Me) (O), Ser, Thr, and Hse; R. sub. 1 is C. sub. 1 -C. sub. 3 primary alkyl, cyclopropylmethyl, allyl, ethylthiomethyl, 2-fluoroethyl, or propargyl; X is bromo, iodo, chloro, methyl, trifluoromethyl, or methoxy; and Z is --CH. sub. 2 OR. sub. 2, ##STR2## in which R. sub. 2 is hydrogen, acetyl, or acetoxymethyl and R. sub. 3 is C. sub. 1 -C. sub. 3 alkyl; are useful analgesic agents.
  • Pharmacologically Active Peptides

    view source
  • US Patent:
    44734972, Sep 25, 1984
  • Filed:
    Mar 7, 1983
  • Appl. No.:
    6/472440
  • Inventors:
    Paul D. Gesellchen - Indianapolis IN
    Robert T. Shuman - Greenwood IN
  • Assignee:
    Eli Lilly and Company - Indianapolis IN
  • International Classification:
    C07C10352
  • US Classification:
    2601125E
  • Abstract:
    Compounds of the formula ##STR1## and pharmaceutically acceptable non-toxic acid addition salts thereof, in which R is hydrogen, methyl, ethyl, cyclopropylmethyl, or allyl; A is a residue of a D-amino acid selected from the group consisting of Ala, Abu, Nva, Val, Nle, Leu, Ile, Gly(Al), Gly(Cp), Met, Cys(Me), Met(O), Cys(Me)(O), Ser, Ser(Me), Thr, and Hse; R. sub. 1 is hydrogen, C. sub. 1 -C. sub. 3 primary alkyl, cyclopropylmethyl, allyl, ethylthiomethyl, 2-fluoroethyl, or propargyl; and X is hydrogen, fluoro, bromo, iodo, chloro, hydroxy, C. sub. 1 -C. sub. 3 alkyl, trifluoromethyl, or C. sub. 1 -C. sub. 2 alkoxy; are useful analgesic agents.

Googleplus

Paul Gesellchen Photo 3

Paul Gesellchen

Lived:
Indianapolis, IN
Omaha, NE
Lincoln, NE, Madison, WI
Work:
Self employed - Consultant
Eli Lilly and Company, Targanta Therapeutics
Education:
N/A, University of Nebraska @ Lincoln, University of Wisconsin @ Madison, Indiana University @ Indianapolis
About:
Raised in Omaha, NE, BS in Chemistry from the Univ of Nebraska, PhD in Pharmaceutical Chemistry from the Univ of Wisconsin, Post Doc in the Biochemitry Dept at the Indiana Medical School in Indianapol...

Youtube

Liver Flush, part 1: Your Liver Needs Love

I finally figured out how to get my slides into the video! Praise the ...

  • Duration:
    42m 20s

Preparation for the No Buy/No Sell Lifestyle

For pdf's of the presentation slides, email at (removing all spaces) C...

  • Duration:
    49m 2s

More Kitchen Remedies--Mamon Wilson

Do you know the health benefits of cabbage go way beyond food! Did you...

  • Duration:
    1h 10m 45s

Charcoal-Comfrey Poultice--Danna Gesellchen

In this video we show the value of using comfrey and charcoal for both...

  • Duration:
    13m 27s

No Buy, No Sell: The Mark of the Beast, Count...

Kalon Gesellchen shares about current world events and how they relate...

  • Duration:
    48m 30s

Danna Gesellchen: Natural Wound Care & Balms,...

Danna Gesellchen discusses wound care and how to care for yourself (an...

  • Duration:
    49m 40s

Classmates

Paul Gesellchen Photo 4

Paul Gesellchen

view source
Schools:
Saunders Elementary School Omaha NE 1953-1962
Community:
Charlene Peckenpaugh, Sally Dean
Paul Gesellchen Photo 5

Saunders Elementary Schoo...

view source
Graduates:
Robyn Neiman (1967-1974),
Kate Jamieson (1964-1965),
Rick Norton (1967-1968),
Paul Gesellchen (1953-1962)
Paul Gesellchen Photo 6

Indiana University - Medi...

view source
Graduates:
Gregory Pupillo (1987-1991),
Michael Sweeney (1976-1979),
Curley Bonds (1987-1992),
Paul Gesellchen (1976-1977)

Facebook

Paul Gesellchen Photo 7

Paul Gesellchen

view source
Friends:
Sondi Greene, Tracie Newman Hager, Bryn Nedderman Bright, Natalie Moore Koriath

Get Report for Paul D Gesellchen from Indianapolis, IN, age ~77
Control profile